niacinamide has been researched along with Diabetic Feet in 5 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Adults with type 2 diabetes mellitus without foot ulcers were administered 400 mg oral 11β-HSD1 inhibitor AZD4017 (n = 14) or placebo (n = 14) bi-daily for 35 days." | 3.11 | Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial. ( Abbas, A; Ajjan, RA; Arlt, W; Del Galdo, F; Fairclough, RJ; Freeman, A; Hensor, EMA; Morgan, AW; Pegg, L; Russell, DA; Shams, K; Stewart, PM; Tahrani, AA; Taylor, AE; Tiganescu, A; Webber, L, 2022) |
| "Diabetic foot ulcer is a serious complication of diabetes, which affects a significant percentage (15%) of diabetics and up to 15%-24% of those affected may require amputation." | 1.43 | Evaluation of wound healing properties of bioactive aqueous fraction from Moringa oleifera Lam on experimentally induced diabetic animal model. ( Abas, F; Arulselvan, P; Cheah, PS; Fakurazi, S; Muhammad, AA, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajjan, RA | 1 |
| Hensor, EMA | 1 |
| Del Galdo, F | 1 |
| Shams, K | 1 |
| Abbas, A | 1 |
| Fairclough, RJ | 1 |
| Webber, L | 1 |
| Pegg, L | 1 |
| Freeman, A | 1 |
| Taylor, AE | 1 |
| Arlt, W | 1 |
| Morgan, AW | 1 |
| Tahrani, AA | 1 |
| Stewart, PM | 1 |
| Russell, DA | 1 |
| Tiganescu, A | 1 |
| Skrypko, V | 1 |
| Kovalenko, A | 1 |
| Zaplutanov, V | 1 |
| Kharitonova, T | 1 |
| Myhaloyko, I | 1 |
| Mikhaloĭko, IIa | 1 |
| Sabadosh, RV | 1 |
| Kovalenko, AL | 2 |
| Skripko, VD | 1 |
| Markevich, PS | 1 |
| Markevich, LB | 1 |
| Plekhanov, AN | 1 |
| Muhammad, AA | 1 |
| Arulselvan, P | 1 |
| Cheah, PS | 1 |
| Abas, F | 1 |
| Fakurazi, S | 1 |
3 trials available for niacinamide and Diabetic Feet
| Article | Year |
|---|---|
Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type | 2022 |
[EFFICACY OF CYTOFLAVIN IN COMPLEX TREATMENT OF DIABETIC FOOT SYNDROME].
Topics: Antioxidants; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabetic Foot; Drug Combinations | 2017 |
[Rationale of application of the drug Cytoflavin in complex treatment of patients with diabetic foot syndrome with mediacalcification arteries].
Topics: Aged; Anti-Bacterial Agents; Antioxidants; Arteries; Combined Modality Therapy; Debridement; Diabete | 2014 |
2 other studies available for niacinamide and Diabetic Feet
| Article | Year |
|---|---|
[THE PHARMACOTHERAPEUTIC EFFICIENCY OF CYTOFLAVIN IN PATIENTS WITH DIABETIC FOOT SYNDROME: IMMEDIATE AND LONG-TERM RESULTS].
Topics: Adult; Aged; Diabetic Foot; Drug Combinations; Female; Flavin Mononucleotide; Humans; Inosine Diphos | 2015 |
Evaluation of wound healing properties of bioactive aqueous fraction from Moringa oleifera Lam on experimentally induced diabetic animal model.
Topics: Animals; Anti-Bacterial Agents; Apigenin; Diabetes Mellitus, Experimental; Diabetic Foot; Disease Mo | 2016 |